Critical Care after Lung Transplantation.
Song Yee KimSu Jin JeongJin Gu LeeMoo Suk ParkHyo Chae PaikSungwon NaJeong Min KimPublished in: Acute and critical care (2018)
Since the first successful lung transplantation in 1983, there have been many advances in the field. Nevertheless, the latest data from the International Society for Heart and Lung Transplantation revealed that the risk of death from transplantation is 9%. Various aspects of postoperative management, including mechanical ventilation, could affect intensive care unit stay, hospital stay, and immediate postoperative morbidity and mortality. Complications such as reperfusion injury, graft rejection, infection, and dehiscence of anastomosis increase fatal adverse side effects immediately after surgery. In this article, we review the possible immediate complications after lung transplantation and summarize current knowledge on prevention and treatment.
Keyphrases
- mechanical ventilation
- extracorporeal membrane oxygenation
- intensive care unit
- acute respiratory distress syndrome
- patients undergoing
- healthcare
- respiratory failure
- acute myocardial infarction
- atrial fibrillation
- adverse drug
- stem cells
- emergency department
- risk factors
- mesenchymal stem cells
- machine learning
- deep learning
- combination therapy
- acute care
- subarachnoid hemorrhage
- cell therapy
- data analysis